Hoimes CJ, Flaig TW, Milowsky MI, Friedlander TW, et al. A plain language summary exploring a new treatment combination for untreated locally advanced or metastatic urothelial cancer: enfortumab vedotin plus pembrolizumab. Future Oncol 2024;20:351-360.
PMID: 37994649